SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as $69.24 and last traded at $69.72, with a volume of 2614060 shares. The stock had previously closed at $73.66.
SPDR S&P Biotech ETF Stock Performance
The stock has a market cap of $4.72 billion, a PE ratio of 11.47 and a beta of 1.00. The business has a 50 day moving average price of $86.82 and a two-hundred day moving average price of $92.53.
SPDR S&P Biotech ETF Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.
Institutional Investors Weigh In On SPDR S&P Biotech ETF
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Golden Cross Stocks: Pattern, Examples and Charts
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- How to Read Stock Charts for Beginners
- Are Tariffs Threatening Disney’s Comeback Story?
- How to Buy Gold Stock and Invest in Gold
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.